Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Hieken, Tina J., Nelson, Garth D., Flotte, Thomas J., Grewal, Eric P., Chen, Jun, McWilliams, Robert R., Kottschade, Lisa A., Yang, Lu, Domingo-Musibay, Evidio, Dronca, Roxana S., Yan, Yiyi, Markovic, Svetomir N., Dimou, Anastasios, Montane, Heather N., Erskine, Courtney L., Piltin, Mara A., Price, Daniel L., Khariwala, Samir S., Hui, Jane, Strand, Carrie A., Harrington, Susan M., Suman, Vera J., Dong, Haidong, Block, Matthew S.
Published in Nature communications (16.02.2024)
Published in Nature communications (16.02.2024)
Get full text
Journal Article
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
Al‐Kali, Aref, Aldoss, Ibrahim, Atherton, Pamela J., Strand, Carrie A., Shah, Bijal, Webster, Jonathan, Bhatnagar, Bhavana, Flatten, Karen S., Peterson, Kevin L., Schneider, Paula A., Buhrow, Sarah A., Kong, Jianping, Reid, Joel M., Adjei, Alex A., Kaufmann, Scott H.
Published in Cancer medicine (Malden, MA) (01.12.2023)
Published in Cancer medicine (Malden, MA) (01.12.2023)
Get full text
Journal Article
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses
Smith, Katherine E R, Peng, Kah-Whye, Pulido, Jose S, Weisbrod, Adam J, Strand, Carrie A, Allred, Jacob B, Newsom, Alysha N, Zhang, Lianwen, Packiriswamy, Nandakumar, Kottke, Timothy, Tonne, Jason M, Moore, Madelyn, Montane, Heather N, Kottschade, Lisa A, McWilliams, Robert R, Dudek, Arkadiusz Z, Yan, Yiyi, Dimou, Anastasios, Markovic, Svetomir N, Federspiel, Mark J, Vile, Richard G, Dronca, Roxana S, Block, Matthew S
Published in Frontiers in immunology (2023)
Published in Frontiers in immunology (2023)
Get full text
Journal Article
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy
Tanabe, Kenneth K., Zahrieh, David, Strand, Carrie A., Hoshida, Yujin, Flotte, Thomas J., Della’Zanna, Gary, Umar, Asad, Chavin, Kenneth D., Cleary, Sean, Kubota, Naoto, Llovet, Josep M., Patel, Tushar, Siegel, Christopher, Limburg, Paul J.
Published in Gastro hep advances (2024)
Published in Gastro hep advances (2024)
Get full text
Journal Article
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)
Luke, Jason J, Olson, Daniel J, Allred, Jacob B, Strand, Carrie A, Bao, Riyue, Zha, Yuanyuan, Carll, Timothy, Labadie, Brian W, Bastos, Bruno R, Butler, Marcus O, Hogg, David, Munster, Pamela N, Schwartz, Gary K
Published in Clinical cancer research (15.02.2020)
Published in Clinical cancer research (15.02.2020)
Get full text
Journal Article
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies
Kalogera, Eleftheria, Nevala, Wendy K, Finnes, Heidi D, Suman, Vera J, Schimke, Jill M, Strand, Carrie A, Kottschade, Lisa A, Kudgus, Rachel A, Buhrow, Sarah A, Becher, Laura R, Geng, Liyi, Glaser, Gretchen E, Grudem, Megan E, Jatoi, Aminah, Klampe, Carolyn M, Kumar, Amanika, Langstraat, Carrie L, McWilliams, Robert R, Wahner Hendrickson, Andrea E, Weroha, S John, Yan, Yiyi, Reid, Joel M, Markovic, Svetomir N, Block, Matthew S
Published in Clinical cancer research (14.06.2024)
Published in Clinical cancer research (14.06.2024)
Get full text
Journal Article
The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT‐01)
Neuman, Heather B., Schumacher, Jessica R., Edge, Stephen B., Ruddy, Kathryn J., Partridge, Ann H., Yu, Menggang, Vanness, David J., Hanlon, Bret M., Le‐Rademacher, Jennifer G., Yang, Dou‐Yan, Havlena, Jeffrey, Strand, Carrie A., Greenberg, Caprice C.
Published in Cancer (01.05.2023)
Published in Cancer (01.05.2023)
Get full text
Journal Article
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target
Bao, Riyue, Surriga, Oliver, Olson, Daniel J, Allred, Jacob B, Strand, Carrie A, Zha, Yuanyuan, Carll, Timothy, Labadie, Brian W, Bastos, Bruno R, Butler, Marcus, Hogg, David, Musi, Elgilda, Ambrosini, Grazia, Munster, Pamela, Schwartz, Gary K, Luke, Jason J
Published in Melanoma research (01.02.2021)
Published in Melanoma research (01.02.2021)
Get more information
Journal Article
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection
Jacobson, Jeffrey M, Zahrieh, David, Strand, Carrie A, Cruz-Correa, Marcia, Pungpapong, Surakit, Roberts, Lewis R, Mandrekar, Sumithra J, Rodriguez, Luz Maria, Boyer, Jean, Marrero, Idania, Kraynyak, Kimberly A, Morrow, Matthew P, Sylvester, Albert J, Pawlicki, Jan M, Gillespie, Elisabeth, Barranco, Eduardo, Richmond, Ellen, Umar, Asad, Weiner, David B, Limburg, Paul J
Published in Cancer prevention research (Philadelphia, Pa.) (01.03.2023)
Published in Cancer prevention research (Philadelphia, Pa.) (01.03.2023)
Get full text
Journal Article
Peptide vaccine with glucopyranosyl lipid A–stable oil-in-water emulsion for patients with resected melanoma
Grewal, Eric P, Erskine, Courtney L, Nevala, Wendy K, Allred, Jacob B, Strand, Carrie A, Kottschade, Lisa A, McWilliams, Robert R, Dronca, Roxana S, Yakovich, Adam J, Markovic, Svetomir N, Block, Matthew S
Published in Immunotherapy (01.09.2020)
Published in Immunotherapy (01.09.2020)
Get full text
Journal Article
Abstract CT114: Pharmacokinetic analysis of navitoclax in combination with sorafenib in patients with relapsed or refractory solid organ tumors
Koubek, Emily J., Costello, Brian A., Yin, Jun, McGovern, Renee M., Buhrow, Sarah A., Schoon, Renee A., Strand, Carrie A., Jiang, Yixing, Borad, Mitesh J., Takebe, Naoko, Kaufmann, Scott H., Adjei, Alex A., Reid, Joel M.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 3031: Pilot study of EGFR inhibition with erlotinib in liver fibrosis for hepatocellular carcinoma prevention
Tanabe, Kenneth K., Zahrieh, David, Strand, Carrie A., Hoshida, Yujin, Flotte, Thomas J., Della’Zanna, Gary, Umar, Asad, Limburg, Paul
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article